Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
Abstract Growth differentiation factor 15 (GDF15) is an endocrine hormone belonging to the TGFβ superfamily member. GDF15 administration or GDF15 overexpression has been reported to have anti-obesity and anti-diabetic effects. Although non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohe...
Guardado en:
Autores principales: | Kook Hwan Kim, Seong Hun Kim, Dai Hoon Han, Young Suk Jo, Yong-ho Lee, Myung-Shik Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32eac4dcab774f319256f97ced562f95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Tae Hyung Kim, et al.
Publicado: (2021) -
Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu HH, et al.
Publicado: (2019) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021) -
Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease
por: Shinkyu Choi, et al.
Publicado: (2021) -
The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
por: Mimi Zhai, et al.
Publicado: (2021)